Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP540199.RAcl6LUCapRsmz35cEk5wo2B0GPmNBgdDjjlCuMqKnLpo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP540199.RAcl6LUCapRsmz35cEk5wo2B0GPmNBgdDjjlCuMqKnLpo130_assertion type Assertion NP540199.RAcl6LUCapRsmz35cEk5wo2B0GPmNBgdDjjlCuMqKnLpo130_head.
- NP540199.RAcl6LUCapRsmz35cEk5wo2B0GPmNBgdDjjlCuMqKnLpo130_assertion description "[We found that (1) a myristoylated HBVpreS/2-48-GST fusion protein efficiently interferes with HBV infection of HepaRG cells; (2) deletions and point mutations in the highly conserved preS1 sequence between amino acids 11 through 21 result in the loss of infection inhibition activity; (3) hepatitis B viruses carrying single amino acid exchanges within this region lose infectivity; and (4) HDV infection of HepaRG cells can be inhibited by myristoylated HBVpreS peptides with the same specificity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP540199.RAcl6LUCapRsmz35cEk5wo2B0GPmNBgdDjjlCuMqKnLpo130_provenance.
- NP540199.RAcl6LUCapRsmz35cEk5wo2B0GPmNBgdDjjlCuMqKnLpo130_assertion evidence source_evidence_literature NP540199.RAcl6LUCapRsmz35cEk5wo2B0GPmNBgdDjjlCuMqKnLpo130_provenance.
- NP540199.RAcl6LUCapRsmz35cEk5wo2B0GPmNBgdDjjlCuMqKnLpo130_assertion SIO_000772 16557545 NP540199.RAcl6LUCapRsmz35cEk5wo2B0GPmNBgdDjjlCuMqKnLpo130_provenance.
- NP540199.RAcl6LUCapRsmz35cEk5wo2B0GPmNBgdDjjlCuMqKnLpo130_assertion wasDerivedFrom befree-20140225 NP540199.RAcl6LUCapRsmz35cEk5wo2B0GPmNBgdDjjlCuMqKnLpo130_provenance.
- NP540199.RAcl6LUCapRsmz35cEk5wo2B0GPmNBgdDjjlCuMqKnLpo130_assertion wasGeneratedBy ECO_0000203 NP540199.RAcl6LUCapRsmz35cEk5wo2B0GPmNBgdDjjlCuMqKnLpo130_provenance.